Logo image of CSF.DE

THALES SA (CSF.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:CSF - FR0000121329 - Common Stock

221.2 EUR
0 (0%)
Last: 12/2/2025, 7:00:00 PM
Fundamental Rating

5

CSF gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 48 industry peers in the Aerospace & Defense industry. CSF has a medium profitability rating, but doesn't score so well on its financial health evaluation. CSF is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CSF had positive earnings in the past year.
In the past year CSF had a positive cash flow from operations.
In the past 5 years CSF has always been profitable.
CSF had a positive operating cash flow in each of the past 5 years.
CSF.DE Yearly Net Income VS EBIT VS OCF VS FCFCSF.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

1.2 Ratios

Looking at the Return On Assets, with a value of 2.74%, CSF is doing worse than 62.50% of the companies in the same industry.
CSF has a Return On Equity (14.93%) which is in line with its industry peers.
CSF has a better Return On Invested Capital (11.65%) than 75.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CSF is in line with the industry average of 9.50%.
The 3 year average ROIC (8.24%) for CSF is below the current ROIC(11.65%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.74%
ROE 14.93%
ROIC 11.65%
ROA(3y)3.15%
ROA(5y)2.86%
ROE(3y)16.5%
ROE(5y)15.14%
ROIC(3y)8.24%
ROIC(5y)7.14%
CSF.DE Yearly ROA, ROE, ROICCSF.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

The Profit Margin of CSF (4.99%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of CSF has grown nicely.
CSF has a Operating Margin of 9.24%. This is comparable to the rest of the industry: CSF outperforms 58.33% of its industry peers.
CSF's Operating Margin has improved in the last couple of years.
CSF has a Gross Margin (26.11%) which is comparable to the rest of the industry.
CSF's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.24%
PM (TTM) 4.99%
GM 26.11%
OM growth 3Y5%
OM growth 5Y2.94%
PM growth 3Y0.86%
PM growth 5Y2.5%
GM growth 3Y1.59%
GM growth 5Y1.22%
CSF.DE Yearly Profit, Operating, Gross MarginsCSF.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CSF is creating some value.
The number of shares outstanding for CSF has been reduced compared to 1 year ago.
Compared to 5 years ago, CSF has less shares outstanding
Compared to 1 year ago, CSF has an improved debt to assets ratio.
CSF.DE Yearly Shares OutstandingCSF.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CSF.DE Yearly Total Debt VS Total AssetsCSF.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

Based on the Altman-Z score of 1.59, we must say that CSF is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.59, CSF is doing worse than 79.17% of the companies in the same industry.
The Debt to FCF ratio of CSF is 3.07, which is a good value as it means it would take CSF, 3.07 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.07, CSF is in the better half of the industry, outperforming 77.08% of the companies in the same industry.
A Debt/Equity ratio of 0.56 indicates that CSF is somewhat dependend on debt financing.
CSF has a Debt to Equity ratio (0.56) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 3.07
Altman-Z 1.59
ROIC/WACC1.52
WACC7.69%
CSF.DE Yearly LT Debt VS Equity VS FCFCSF.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

CSF has a Current Ratio of 0.82. This is a bad value and indicates that CSF is not financially healthy enough and could expect problems in meeting its short term obligations.
CSF has a worse Current ratio (0.82) than 93.75% of its industry peers.
A Quick Ratio of 0.61 indicates that CSF may have some problems paying its short term obligations.
With a Quick ratio value of 0.61, CSF is not doing good in the industry: 68.75% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.61
CSF.DE Yearly Current Assets VS Current LiabilitesCSF.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

5

3. Growth

3.1 Past

CSF shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22.91%.
The Earnings Per Share has been growing slightly by 5.55% on average over the past years.
CSF shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.16%.
CSF shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.26% yearly.
EPS 1Y (TTM)-22.91%
EPS 3Y10.55%
EPS 5Y5.55%
EPS Q2Q%-34.49%
Revenue 1Y (TTM)11.16%
Revenue growth 3Y8.32%
Revenue growth 5Y2.26%
Sales Q2Q%8.14%

3.2 Future

The Earnings Per Share is expected to grow by 12.82% on average over the next years. This is quite good.
CSF is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.08% yearly.
EPS Next Y10.26%
EPS Next 2Y13.58%
EPS Next 3Y13.1%
EPS Next 5Y12.82%
Revenue Next Year9.05%
Revenue Next 2Y8.21%
Revenue Next 3Y8.12%
Revenue Next 5Y8.08%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CSF.DE Yearly Revenue VS EstimatesCSF.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B
CSF.DE Yearly EPS VS EstimatesCSF.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 42.79 indicates a quite expensive valuation of CSF.
CSF's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 26.15, CSF is valued quite expensively.
A Price/Forward Earnings ratio of 19.47 indicates a rather expensive valuation of CSF.
CSF's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CSF is cheaper than 79.17% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 36.22. CSF is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 42.79
Fwd PE 19.47
CSF.DE Price Earnings VS Forward Price EarningsCSF.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CSF indicates a somewhat cheap valuation: CSF is cheaper than 72.92% of the companies listed in the same industry.
CSF's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CSF is cheaper than 85.42% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.13
EV/EBITDA 15.72
CSF.DE Per share dataCSF.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
CSF has a very decent profitability rating, which may justify a higher PE ratio.
CSF's earnings are expected to grow with 13.10% in the coming years. This may justify a more expensive valuation.
PEG (NY)4.17
PEG (5Y)7.71
EPS Next 2Y13.58%
EPS Next 3Y13.1%

5

5. Dividend

5.1 Amount

CSF has a Yearly Dividend Yield of 1.68%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 1.21, CSF pays a better dividend. On top of this CSF pays more dividend than 83.33% of the companies listed in the same industry.
Compared to the average S&P500 Dividend Yield of 2.32, CSF is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.68%

5.2 History

On average, the dividend of CSF grows each year by 9.56%, which is quite nice.
Dividend Growth(5Y)9.56%
Div Incr YearsN/A
Div Non Decr YearsN/A
CSF.DE Yearly Dividends per shareCSF.DE Yearly Dividends per shareYearly Dividends per share 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

71.25% of the earnings are spent on dividend by CSF. This is not a sustainable payout ratio.
CSF's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP71.25%
EPS Next 2Y13.58%
EPS Next 3Y13.1%
CSF.DE Yearly Income VS Free CF VS DividendCSF.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
CSF.DE Dividend Payout.CSF.DE Dividend Payout, showing the Payout Ratio.CSF.DE Dividend Payout.PayoutRetained Earnings

THALES SA

FRA:CSF (12/2/2025, 7:00:00 PM)

221.2

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)10-23 2025-10-23
Earnings (Next)03-03 2026-03-03/amc
Inst Owners22.57%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap45.55B
Revenue(TTM)21.35B
Net Income(TTM)1.07B
Analysts77.78
Price Target286.88 (29.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.68%
Yearly Dividend3.44
Dividend Growth(5Y)9.56%
DP71.25%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.1%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.26%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.17%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 42.79
Fwd PE 19.47
P/S 2.13
P/FCF 19.13
P/OCF 14.96
P/B 6.38
P/tB N/A
EV/EBITDA 15.72
EPS(TTM)5.17
EY2.34%
EPS(NY)11.36
Fwd EY5.14%
FCF(TTM)11.56
FCFY5.23%
OCF(TTM)14.78
OCFY6.68%
SpS103.67
BVpS34.66
TBVpS-17.3
PEG (NY)4.17
PEG (5Y)7.71
Graham Number63.5
Profitability
Industry RankSector Rank
ROA 2.74%
ROE 14.93%
ROCE 14.78%
ROIC 11.65%
ROICexc 16.44%
ROICexgc N/A
OM 9.24%
PM (TTM) 4.99%
GM 26.11%
FCFM 11.15%
ROA(3y)3.15%
ROA(5y)2.86%
ROE(3y)16.5%
ROE(5y)15.14%
ROIC(3y)8.24%
ROIC(5y)7.14%
ROICexc(3y)11.9%
ROICexc(5y)10.41%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)11.53%
ROCE(5y)9.88%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y8.3%
ROICexc growth 5Y6.21%
OM growth 3Y5%
OM growth 5Y2.94%
PM growth 3Y0.86%
PM growth 5Y2.5%
GM growth 3Y1.59%
GM growth 5Y1.22%
F-Score7
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 3.07
Debt/EBITDA 1.3
Cap/Depr 58.17%
Cap/Sales 3.11%
Interest Coverage 8.8
Cash Conversion 97.8%
Profit Quality 223.37%
Current Ratio 0.82
Quick Ratio 0.61
Altman-Z 1.59
F-Score7
WACC7.69%
ROIC/WACC1.52
Cap/Depr(3y)54.76%
Cap/Depr(5y)48.08%
Cap/Sales(3y)3.16%
Cap/Sales(5y)2.94%
Profit Quality(3y)143.57%
Profit Quality(5y)182.78%
High Growth Momentum
Growth
EPS 1Y (TTM)-22.91%
EPS 3Y10.55%
EPS 5Y5.55%
EPS Q2Q%-34.49%
EPS Next Y10.26%
EPS Next 2Y13.58%
EPS Next 3Y13.1%
EPS Next 5Y12.82%
Revenue 1Y (TTM)11.16%
Revenue growth 3Y8.32%
Revenue growth 5Y2.26%
Sales Q2Q%8.14%
Revenue Next Year9.05%
Revenue Next 2Y8.21%
Revenue Next 3Y8.12%
Revenue Next 5Y8.08%
EBIT growth 1Y17.28%
EBIT growth 3Y13.73%
EBIT growth 5Y5.27%
EBIT Next Year47.96%
EBIT Next 3Y21.02%
EBIT Next 5Y16.04%
FCF growth 1Y47.67%
FCF growth 3Y-7.33%
FCF growth 5Y8.4%
OCF growth 1Y36.71%
OCF growth 3Y-3.84%
OCF growth 5Y7.31%

THALES SA / CSF.DE FAQ

Can you provide the ChartMill fundamental rating for THALES SA?

ChartMill assigns a fundamental rating of 5 / 10 to CSF.DE.


What is the valuation status of THALES SA (CSF.DE) stock?

ChartMill assigns a valuation rating of 4 / 10 to THALES SA (CSF.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for THALES SA?

THALES SA (CSF.DE) has a profitability rating of 6 / 10.


What is the earnings growth outlook for THALES SA?

The Earnings per Share (EPS) of THALES SA (CSF.DE) is expected to grow by 10.26% in the next year.


Is the dividend of THALES SA sustainable?

The dividend rating of THALES SA (CSF.DE) is 5 / 10 and the dividend payout ratio is 71.25%.